Hence, targeting FGF2 holds promise, as demonstrated in cardiac fibrosis studies.33 As for EHD2, previous studies have linked this gene, which encodes a membrane transport regulatory protein, with mouse embryonic fibroblasts and liver cirrhosis.34 Our study is the first to establish a correlation between EHD2 and intestinal fibrosis in humans, prompting further exploration of its potential as a biomarker and therapeutic target. The gene discussed is FGF2; the disease is cirrhosis of liver.